AS Stock

Business

Merck Bets on Precision Oncology with Strategic Eikon Investment and Guardant Health Alliance

Merck & Co. is laying the groundwork for its future in oncology beyond Keytruda, announcing a strategic investment in biotech Eikon Therapeutics and a major collaboration with diagnostic leader Guardant Health. The moves signal a targeted, partnership-driven strategy to bolster its pipeline and diagnostics capabilities in the competitive cancer therapy market.

Feb 2, 2026

Business

Fabrinet Shatters Records with 36% Revenue Surge, Fueled by AI and Telecom Boom

Fabrinet's Q2 2026 earnings reveal a historic quarter, with revenue hitting $1.13B driven by explosive growth in high-performance computing and telecom. The company signals sustained momentum with aggressive capacity expansion.

Feb 2, 2026

Business

AMD's Earnings Preview: Options Market Bets on Continued Rally After Strong Pre-Announcement Run

With Advanced Micro Devices set to report Q4 results, derivatives traders are pricing in a significant post-earnings move, betting the chipmaker's momentum can extend its recent 25% surge from yearly lows.

Feb 2, 2026

Business

GM's Barra Joins Trump for Critical Minerals Reserve Announcement, Stressing Supply Chain Resilience

General Motors CEO Mary Barra attended a White House event where President Trump unveiled 'Project Vault,' a $12 billion initiative to create a strategic reserve of critical minerals aimed at securing U.S. industrial supply chains.

Feb 2, 2026

Business

Grains in the Crosshairs: How Metals Meltdown and Dollar Woes Shape This Week's Trade

After historic sell-offs in gold and silver rattled commodity markets, traders of corn, soybeans, and wheat are navigating a landscape influenced by external financial shocks, weather threats, and shifting demand signals.

Feb 2, 2026

Business

Palantir Earnings Preview: Options Market Bets on Rebound After Recent Slide

Despite Palantir shares trading below $150 ahead of its Q4 report, derivatives activity and analyst commentary point to expectations for a significant post-earnings recovery, driven by sustained commercial and government contract momentum.

Feb 2, 2026

Business

Frontken's Strong Fundamentals Defy Recent Share Slump: Is the Market Overlooking a Gem?

Despite a 14% share price decline over three months, Frontken Corporation Berhad (KLSE:FRONTKN) exhibits robust financial health, highlighted by a superior Return on Equity. Analysts suggest the sell-off may be a buying opportunity for long-term investors.

Feb 2, 2026

Business

Kawan Food Berhad's Three-Year Slump Tests Investor Patience Amid Market Rebound

While Malaysian markets have climbed, shareholders of frozen food producer Kawan Food Berhad have watched their investment value nearly halve over three turbulent years, raising questions about the company's strategic direction and recovery prospects.

Feb 2, 2026

Business

SAP's Cloud Slowdown Sparks Investor Jitters Over AI Transition and Growth Trajectory

SAP's latest quarterly earnings revealed a significant deceleration in its crucial cloud business growth, sending shares tumbling and raising fresh doubts about the enterprise software giant's positioning in an AI-dominated future.

Feb 2, 2026

Business

York Space Systems Soars in Market Debut, But Can It Navigate the Satellite Sector's Turbulence?

York Space Systems (YSS) launched onto the public market with a strong first-day pop, capitalizing on defense spending trends and a push for scalable satellite manufacturing. Yet, its path is fraught with competition and the financial growing pains typical of a capital-intensive industry.

Feb 2, 2026

Business

Meta Poised to Lead 'Magnificent Seven' in 2026, Betting Big on AI Pivot

While its metaverse venture stumbles, Meta Platforms' core advertising engine and strategic shift toward artificial intelligence are convincing analysts it remains the top contender for outperformance among tech's elite group by 2026.

Feb 2, 2026

Business

Gold's Wild Ride Leaves London's Historic Jewellery Quarter Reeling

The dramatic surge and sudden plunge in precious metal prices have thrown London's famed Hatton Garden into chaos, forcing jewellers, refiners, and families to navigate a volatile market with significant financial consequences.

Feb 2, 2026

Business

Cotton Futures Pare Losses Amid Trump-Modi Trade Deal Announcement

Cotton futures trimmed early losses by midday Thursday, recovering slightly despite broader market pressure. The partial rebound followed a surprise announcement from former President Donald Trump regarding a new trade agreement with India, a key cotton importer.

Feb 2, 2026

Business

The $1 Million Retirement Question: Is It Enough for Your Golden Years?

While a seven-figure nest egg is a common retirement goal, financial experts caution that its sufficiency hinges on withdrawal strategies, lifestyle expectations, and supplemental income.

Feb 2, 2026

Business

Analysts Boost Targets for KalVista Ahead of Key Q4 Report, Citing Oral HAE Therapy Potential

TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.

Feb 2, 2026

Business

Dream Job vs. Underwater Mortgage: Florida Software Engineer Weighs $70K Loss for Career Change

A high-earning Orlando software engineer faces a stark choice: pursue a lifelong dream in federal law enforcement at a major pay cut and a significant real estate loss, or stay put in a lucrative tech career. His story highlights the personal costs behind shifting housing markets and career pivots.

Feb 2, 2026

Business

Werner Enterprises Soars on Strategic Acquisition, Expanding Dedicated Fleet by Half

Shares of Werner Enterprises (WERN) surged 6% following the announcement of its acquisition of FirstFleet, a move that significantly bolsters its dedicated transportation division and market position.

Feb 2, 2026

Business

Beyond the Benchmark: Three Fidelity ETFs Poised to Outpace the S&P 500

While the S&P 500 remains a core holding for many, actively managed and thematic ETFs offer a path to potentially superior returns. We analyze three Fidelity funds with distinct strategies—from U.S. tech dominance to international dividend income—that have historically beaten the market.

Feb 2, 2026

Business

Analysts Trim MiMedx Targets Amid Regulatory Shifts in Wound Care Coverage

Craig-Hallum and Northland Securities have both lowered price targets for MiMedx Group (MDXG), citing near-term uncertainty following new CMS billing guidance for skin substitute products, though both firms maintain positive long-term ratings.

Feb 2, 2026

Business

Jim Cramer Doubles Down on NVIDIA: 'The Undisputed Leader in the AI Race'

CNBC's Jim Cramer reaffirms his bullish stance on NVIDIA, calling the chipmaker the dominant force in the rapidly evolving artificial intelligence landscape, while analysts debate the sustainability of its market position.

Feb 2, 2026